Publiziert in: Marktpuls, Unternehmen
Frei

Invitation to Roche’s Pharma Day 2022 Mittwoch, 03. August 2022 - 10:07

Investor Update  ?v=11232021124200
Invitation to Roche's Pharma Day 2022
 

 

ba92484c-0d50-4d89-b86d-57667f7cdaf4

 

The Roche Investor Relations team would like to invite you to the Roche Pharma Day that will take place in London on Monday, 12th September 2022, starting at 10:30 BST and will finish at 14:30 BST with a reception.

The Roche Pharma Day will address the following topics:

 

  • Pharma strategy, portfolio planning, productivity & new technologies
  • Market opportunities, on-going launches, pricing & access
  • Late stage pipeline update in oncology, neuroscience, immunology, infectious diseases & ophthalmology

 

Speakers will include Bill Anderson, Teresa Graham, Levi Garraway, Paulo Fontoura and Christopher Brittain. You will have the opportunity to meet senior management during the event.

Meeting information: 
Date/Time (BST):
Monday, 12th September 2022
10:00 Registration
10:30 Event starts
14:30 Event ends, followed by a reception with Roche Management Team

Venue
etc.venues St Paul's
200 Aldersgate
London EC1A 4HD
map

To register for the event please follow this > link (passcode: Pharma2022)

 

The slides will be available for download at 9:30 BST on the day of the event.
> click here

 

Alternatively you may participate virtually in the webinar. (no access to speakers, pre-registration required)

Please pre-register for the webinar here*.

 

Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com.

 

A replay of the event will be available via > ir.roche.com

*privacy notice

 

Best regards,

 

 

Bruno Eschli
Head of Investor Relations

 

 

 

 

Roche Investor Relations

 

Dr. Bruno Eschli

Phone: +41 61 68-75284

e-mail: bruno.eschli@roche.com

 

Dr. Sabine Borngräber

Phone: +41 61 68-88027

e-mail: sabine.borngraeber@roche.com

 

Dr. Birgit Masjost

Phone: +41 61 68-84814

e-mail: birgit.masjost@roche.com

 

Dr. Gerard Tobin

Phone: +41 61 68-72942

e-mail: gerard.tobin@roche.com

Investor Relations North America

 

Loren Kalm

Phone: +1 650 225 3217

e-mail: kalm.loren@gene.com

 

 

 

 

All rights reserved ©2022 F. Hoffmann-La Roche Ltd.
Group Communications, Grenzacherstrasse 124, CH-4070 Basel, Switzerland